4
Changes in Ownership
Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-25-033719
Co-Chief Executive Officer sold 4,595 shares at $3.17 ($14,549)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Joshua B Co-Chief Executive Officer | 2025-03-03 | Sale | −4,595 | $3.17 | $14,549 | 3,196,652 | D |
| Open-market sales · 4,595 sh · avg $3.17 · $14,549 | |||||||
Loading xslF345X05/ownership.xml…